Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Black Diamond Therapeutics (BDTX) Profit After Tax: 2018-2021

Historic Profit After Tax for Black Diamond Therapeutics (BDTX) over the last 4 years, with Dec 2021 value amounting to -$125.6 million.

  • Black Diamond Therapeutics' Profit After Tax fell 14.32% to -$25.9 million in Q4 2021 from the same period last year, while for Dec 2021 it was -$113.9 million, marking a year-over-year decrease of 69.31%. This contributed to the annual value of -$125.6 million for FY2021, which is 86.75% down from last year.
  • Per Black Diamond Therapeutics' latest filing, its Profit After Tax stood at -$125.6 million for FY2021, which was down 86.75% from -$67.3 million recorded in FY2020.
  • In the past 5 years, Black Diamond Therapeutics' Profit After Tax registered a high of -$8.9 million during FY2018, and its lowest value of -$125.6 million during FY2021.
  • Over the past 3 years, Black Diamond Therapeutics' median Profit After Tax value was -$67.3 million (recorded in 2020), while the average stood at -$76.0 million.
  • Data for Black Diamond Therapeutics' Profit After Tax shows a maximum YoY tumbled of 294.78% (in 2019) over the last 5 years.
  • Yearly analysis of 4 years shows Black Diamond Therapeutics' Profit After Tax stood at -$8.9 million in 2018, then crashed by 294.78% to -$35.3 million in 2019, then tumbled by 90.75% to -$67.3 million in 2020, then tumbled by 86.75% to -$125.6 million in 2021.